Table 3.
Item | Mean | SE | Distribution for PSA | Source |
---|---|---|---|---|
Utilities | ||||
Complete protectionb | 0.9 | 0.18 | Beta | Cawston 2017 [20] |
Complete responsec | 0.7 | 0.14 | Beta | Cawston 2017 [20] |
Incomplete responsed | 0.24 | 0.048 | Beta | Cawston 2017 [20] |
HCRU costa | ||||
Cost per patient with severe nauseae | $9920 | $820 | Gamma | Burke 2011 [5] |
HCRU, healthcare resource use; PSA, probabilistic sensitivity analysis; SE, standard error
aAdjusted to 2018 US dollars
bComplete protection (CP) defined as absence of any of an emetic episode or use of rescue medication and no significant nausea (visual analogue scale [VAS] score < 25 mm)
cComplete response (CR) defined as no emetic episodes or rescue medication with a VAS score ≥ 25 mm
dIncomplete response (IR) if there was no CP or CR
eSevere nausea defined as VAS > 80 mm